Prophylaxis of Hematologic Complications With Naderin in First-Line Breast Cancer Chemotherapy

NCT07671547 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

79

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Hematologic Disorder
Leukopenia
Chemotherapy-Induced Myelosuppression

Interventions

DRUG: Naderin
DRUG: AC Chemotherapy

Sponsor

MIPO Clinic

Collaborators

[object Object]